Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000129675 | SCV000184474 | uncertain significance | Hereditary cancer-predisposing syndrome | 2023-11-28 | criteria provided, single submitter | clinical testing | The p.F358L variant (also known as c.1072T>C), located in coding exon 12 of the MUTYH gene, results from a T to C substitution at nucleotide position 1072. The phenylalanine at codon 358 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000226144 | SCV000285914 | uncertain significance | Familial adenomatous polyposis 2 | 2023-12-04 | criteria provided, single submitter | clinical testing | This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 358 of the MUTYH protein (p.Phe358Leu). This variant is present in population databases (rs587781601, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with MUTYH-related conditions. ClinVar contains an entry for this variant (Variation ID: 141246). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Counsyl | RCV000226144 | SCV000487358 | uncertain significance | Familial adenomatous polyposis 2 | 2016-05-23 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000129675 | SCV000685537 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-09-09 | criteria provided, single submitter | clinical testing | This missense variant replaces phenylalanine with leucine at codon 358 of the MUTYH protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has been identified in 5/248812 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759879 | SCV000889519 | uncertain significance | not provided | 2018-03-22 | criteria provided, single submitter | clinical testing |